Skip to main content

Table 3 Multivariate overall survival analysis of different clinical stages in CRC patients with different sites

From: Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer

 

Cecum

Ascending colon

HR (95% CI)

Transverse colon

HR (95% CI)

Descending colon

HR (95% CI)

Sigmoid colon

HR (95% CI)

Rectum

HR (95% CI)

Stage at presentation

 Stage 0

1.00

0.77 (0.6–0.99)*

1.37 (0.96–1.96)

1.36 (1.01–1.83)*

1 (0.72–1.39)

1.07 (0.68–1.68)

 Stage I

1.00

0.72 (0.68–0.75)**

1.02 (0.95–1.09)

1.15 (1.08–1.21)**

1.07 (1.01–1.14)*

1.07 (0.98–1.16)

 Stage II

1.00

0.81 (0.78–0.84)**

0.92 (0.88–0.96)**

0.96 (0.93–1)

1.01 (0.97–1.05)

0.94 (0.89–0.99)*

 Stage III

1.00

0.63 (0.61–0.65)**

1 (0.96–1.04)

1.12 (1.08–1.16)**

1.05 (1.01–1.09)*

0.93 (0.88–0.97)*

 Stage IV

1.00

0.6 (0.58–0.62)**

0.94 (0.89–0.98)*

1.07 (1.03–1.11)*

0.95 (0.91–0.99)*

0.93 (0.89–0.98)*

 All stages

1.00

0.7 (0.69–0.71)**

0.95 (0.93–0.97)**

0.97 (0.95–0.99)*

1.04 (1.02–1.07)**

0.96 (0.93–0.98)*

  1. ** p < 0.001, *p < 0.05; CI confidence interval, HR hazard ratio. The classification criteria of stages refer to the AJCC/UICC TNM staging system. The cecum cancer group was set to 1 as the control group